Aequitas Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 31-07-2024
- Paid Up Capital ₹ 4.37 M
as on 31-07-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 Cr
as on 31-07-2024
- Satisfied Charges ₹ 2.85 Cr
as on 31-07-2024
- Revenue 10.21%
(FY 2023)
- Profit -83.62%
(FY 2023)
- Ebitda -62.38%
(FY 2023)
- Net Worth 18.37%
(FY 2023)
- Total Assets 1.59%
(FY 2023)
About Aequitas Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.37 M.
The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹2.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinod Malhotra, Shailesh Kamat, and Anil Tikoo serve as directors at the Company.
- CIN/LLPIN
U36994MH2017PTC299446
- Company No.
299446
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aequitas Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Tikoo  | Director | 13-Jan-2018 | Current |
| Vinod Malhotra | Director | 24-Oct-2017 | Current |
| Shailesh Kamat | Director | 07-Sep-2017 | Current |
Financial Performance of Aequitas Healthcare.
Aequitas Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.21% increase. The company also saw a substantial fall in profitability, with a 83.62% decrease in profit. The company's net worth Soared by an impressive increase of 18.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aequitas Healthcare?
In 2023, Aequitas Healthcare had a promoter holding of 29.44% and a public holding of 70.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 May 2023 | ₹4.50 Cr | Open |
Axis Bank Limited Creation Date: 27 Aug 2021 | ₹8.50 M | Satisfied |
Hdfc Bank Limited Creation Date: 21 Jun 2021 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Aequitas Healthcare?
Aequitas Healthcare has a workforce of 73 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aequitas Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aequitas Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
